iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy

Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune Fortifying RNAs (UNIFYRs™) as a new class of RNA therapeutics poised to transform cancer treatment. GAINESVILLE, Fla., Oct. 19, 2025 /PRNewswire/ -- iOncologi, Inc., a...